These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 36991064)

  • 21. Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
    Barbato E; Azizi M; Schmieder RE; Lauder L; Böhm M; Brouwers S; Bruno RM; Dudek D; Kahan T; Kandzari DE; Lüscher TF; Parati G; Pathak A; Ribichini FL; Schlaich MP; Sharp ASP; Sudano I; Volpe M; Tsioufis C; Wijns W; Mahfoud F
    Eur Heart J; 2023 Apr; 44(15):1313-1330. PubMed ID: 36790101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcome of renal nerve denervation (RDN) for resistant hypertension.
    Panchavinnin P; Wanthong S; Roubsanthisuk W; Tresukosol D; Buranakitjaroen P; Chotruangnapa C; Watanapa W; Pongakasira R; Wongpraparut N
    Hypertens Res; 2022 Jun; 45(6):962-966. PubMed ID: 35393514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2022 Malaysian Working Group Consensus Statement on Renal Denervation for management of arterial hypertension.
    Chia YC; Wan Ahmad WA; Fong AYY; Rosman A; Abdul Rahman AR; Choo GH; Lim SK; Abu Bakar MZ; Ong TK
    Hypertens Res; 2022 Jul; 45(7):1111-1122. PubMed ID: 35650248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal denervation.
    Olsen LK; Kamper AL; Svendsen JH; Feldt-Rasmussen B
    Eur J Intern Med; 2015 Mar; 26(2):95-105. PubMed ID: 25676808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of sympathetic mapping and ablation of renal nerves for the treatment of hypertension (SMART): 6-month follow-up of a randomised, controlled trial.
    Wang J; Yin Y; Lu C; Lu Z; Hu J; Wang Y; Ge J; Jiang H; Yao C; Yan X; Ma W; Qi X; Dang Y; Chen S; Zhu J; Wang D; Ding C; Wang W; Liu J; Wang Y; Li H; Pan Z; Cui K; Li C; Liang X; Chen W; Sobotka PA; Zhang J; Esler M; Sun N; Chen M; Huo Y
    EClinicalMedicine; 2024 Jun; 72():102626. PubMed ID: 38756107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2019 Consensus Statement of the Taiwan Hypertension Society and the Taiwan Society of Cardiology on Renal Denervation for the Management of Arterial Hypertension.
    Wang TD; Lee YH; Chang SS; Tung YC; Yeh CF; Lin YH; Pan CT; Hsu CY; Huang CY; Wu CK; Sung PH; Chiang LT; Wang YC; Tsai WC; Lin TT; Lin CP; Chen WJ; Hwang JJ
    Acta Cardiol Sin; 2019 May; 35(3):199-230. PubMed ID: 31249454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of renal sympathetic innervation: recent insights beyond blood pressure control.
    Linz D; Hohl M; Elliott AD; Lau DH; Mahfoud F; Esler MD; Sanders P; Böhm M
    Clin Auton Res; 2018 Aug; 28(4):375-384. PubMed ID: 29429026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal and hypothalamic inflammation in renovascular hypertension: role of afferent renal nerves.
    Lauar MR; Evans LC; Van Helden D; Fink GD; Banek CT; Menani JV; Osborn JW
    Am J Physiol Regul Integr Comp Physiol; 2023 Oct; 325(4):R411-R422. PubMed ID: 37519252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The randomised Oslo study of renal denervation
    Bergland OU; Søraas CL; Larstorp ACK; Halvorsen LV; Hjørnholm U; Hoffman P; Høieggen A; Fadl Elmula FEM
    Blood Press; 2021 Feb; 30(1):41-50. PubMed ID: 33030064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal denervation in the era of HTN-3. Comprehensive review and glimpse into the future.
    Silva JD; Costa M; Gersh BJ; Gonçalves L
    J Am Soc Hypertens; 2016 Aug; 10(8):656-70. PubMed ID: 27319336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective Renal Denervation Guided by Renal Nerve Stimulation in Canine.
    Liu H; Chen W; Lai Y; Du H; Wang Z; Xu Y; Ling Z; Fan J; Xiao P; Zhang B; Wang J; Gyawali L; Zrenner B; Woo K; Yin Y
    Hypertension; 2019 Sep; 74(3):536-545. PubMed ID: 31327262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal denervation enhances GABA-ergic input into the PVN leading to blood pressure lowering in chronic kidney disease.
    Nishihara M; Takesue K; Hirooka Y
    Auton Neurosci; 2017 May; 204():88-97. PubMed ID: 27729205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal Innervation in Resistant Hypertension: A Review of Pathophysiology and Renal Denervation as Potential Treatment.
    Wilson AL; Gandhi J; Suh Y; Joshi G; Smith NL; Khan SA
    Curr Hypertens Rev; 2020; 16(2):115-127. PubMed ID: 30827252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal nerve stimulation identifies renal innervation and optimizes the strategy for renal denervation in canine.
    Liu H; Li Y; Zhou H; Chen W; Xu Y; Du H; Zhang B; Xia T; Li D; Ou Z; Tang R; Chen Q; Zhao B; Yin Y
    J Transl Med; 2023 Feb; 21(1):100. PubMed ID: 36759871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale and Design of Sympathetic Mapping/Ablation of Renal Nerves Trial (SMART) for the Treatment of Hypertension: a Prospective, Multicenter, Single-Blind, Randomized and Sham Procedure-Controlled Study.
    Wang J; Sun N; Ge J; Jiang H; Yin Y; Chen M; Wang Y; Yao C; Yan X; Sobotka PA; Huo Y
    J Cardiovasc Transl Res; 2023 Apr; 16(2):358-370. PubMed ID: 36042146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of catheter-based radiofrequency renal denervation in stented renal arteries.
    Mahfoud F; Tunev S; Ruwart J; Schulz-Jander D; Cremers B; Linz D; Zeller T; Bhatt DL; Rocha-Singh K; Böhm M; Melder RJ
    Circ Cardiovasc Interv; 2014 Dec; 7(6):813-20. PubMed ID: 25336466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The current status of renal denervation for the treatment of arterial hypertension.
    Lauder L; Böhm M; Mahfoud F
    Prog Cardiovasc Dis; 2021; 65():76-83. PubMed ID: 33587963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease.
    Schlaich MP; Bart B; Hering D; Walton A; Marusic P; Mahfoud F; Böhm M; Lambert EA; Krum H; Sobotka PA; Schmieder RE; Ika-Sari C; Eikelis N; Straznicky N; Lambert GW; Esler MD
    Int J Cardiol; 2013 Oct; 168(3):2214-20. PubMed ID: 23453868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistant hypertension: Renal denervation or pharmacovigilance? Insights from a renal denervation screening program.
    Ojrzanowski M; Kasprzak JD; Peruga JZ; Kurpesa M; Jankowski Ł; Sahni S; Plewka M
    Adv Clin Exp Med; 2019 Nov; 28(11):1525-1530. PubMed ID: 31693316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal Denervation in the treatment of Resistant Hypertension.
    Yap LB; Balachandran K
    Med J Malaysia; 2021 Nov; 76(6):893-897. PubMed ID: 34806679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.